A Study Comparing Pemetrexed Plus Cisplatin Versus Pemetrexed Alone in NSCLC Patients Who Have Progressed on First Line EGFR-TKI
Clinical trial NCT03050437 · UNKNOWN
Trial details
- NCT number
- NCT03050437
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2017-02-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.